What Researchers Did
Researchers tested several cancer drugs in a tumor growth delay assay, combined with different doses of Fluosol-DA, under normal air, carbogen breathing, or hyperbaric 100% oxygen breathing, to see whether the drugs' antitumor activity would improve.
What They Found
This tumor growth delay study, which tested drugs from several classes, reports that adding Fluosol-DA and carbogen breathing to anticancer drugs can significantly enhance tumor growth delay compared with the drug plus air breathing. The best conditions for tumor response depended on the drug, the oxygenation level and duration, and the dose of the perfluorochemical emulsion. The conditions tested were normal aeration, carbogen for 1-2 hours or 6 hours, and hyperbaric 100% oxygen at 3 atmospheres for 1 hour. The abstract does not report results for the hyperbaric oxygen condition alone, and it gives no sample sizes or other numbers.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract gives no numbers, sample sizes or statistical tests, and it does not say how the hyperbaric oxygen condition performed, so the size and reliability of the findings cannot be judged from it.